CXCR4 and neoplasm: Meanwhile, CXCR4 antagonism via the “patching” removes physical barriers by alleviating desmoplasia (Fig. 6b) and reduces immunological barriers by reversing immunosuppression (Supplementary Fig. 16), which paves the way for T cell penetration and tumor-reactive activity.